An expert multi-disciplinary team from the National Centre for Cancer Care and Research (NCCCR), part of the Hamad Medical Corporation (HMC), has performed Qatar’s first allogeneic hematopoietic stem cell transplantation on a 32-year-old female patient diagnosed with acute myeloid leukaemia.
Acute myeloid leukaemia (AML) is an aggressive form of blood cancer.
Allogeneic stem cell transplantation involves the transfer of stem cells from a genetically-similar healthy person to a patient following high-intensity chemotherapy or radiation.
It is used to eliminate cancer and restore a patient’s blood and immune systems.
Due to the time it takes to build the immune system back up after the transplant, several months of close expert monitoring is needed to prevent complications following the procedure.
The patient, a mother of four, was diagnosed with AML earlier this year after noticing unexplained bruising on her upper and lower limbs.
She visited her doctor and underwent blood tests which revealed hyper leukocytosis – an indication of AML.
She was quickly admitted to NCCCR where…